Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations

OBJECTIVE: To investigate the clinical features of patients with non-small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor (EGFR) mutations, and the treatment outcomes of EGFR tyrosine kinase inhibitors (TKIs) in these patients. METHODS: We retrospectively analyzed the d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chin J Cancer Res
Main Authors: Zhang, Yan, Wang, Zheng, Hao, Xuezhi, Hu, Xingsheng, Wang, Hongyu, Wang, Yan, Ying, Jianming
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5348472/
https://ncbi.nlm.nih.gov/pubmed/28373750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.03
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares